CeeNU Interactions
There are 272 drugs known to interact with CeeNU (lomustine), along with 5 disease interactions. Of the total drug interactions, 55 are major, 200 are moderate, and 17 are minor.
- View all 272 medications that may interact with CeeNU
- View CeeNU disease interactions (5)
Most frequently checked interactions
View interaction reports for CeeNU (lomustine) and the medicines listed below.
- Adriamycin (doxorubicin)
- Advate (antihemophilic factor)
- betamethasone
- Blenoxane (bleomycin)
- cefazolin
- Cetrotide (cetrorelix)
- Cleocin (clindamycin)
- Cleocin Ovules (clindamycin topical)
- clonazepam
- conjugated estrogens / meprobamate
- Cytovene (ganciclovir)
- Cytoxan (cyclophosphamide)
- Depakene (valproic acid)
- Diacomit (stiripentol)
- Diamox (acetazolamide)
- Epogen (epoetin alfa)
- Exjade (deferasirox)
- Extraneal (lvp solution)
- febuxostat
- Feiba (anti-inhibitor coagulant complex)
- Gonal-f (follicle stimulating hormone)
- Hemlibra (emicizumab)
- Hizentra (immune globulin subcutaneous)
- Ingrezza (valbenazine)
- Kalydeco (ivacaftor)
- Matulane (procarbazine)
- Metro (metronidazole)
- Morphine Sulfate SR (morphine)
- NovoSeven RT (coagulation factor viia)
- Nutropin Depot (somatropin)
CeeNU disease interactions
There are 5 disease interactions with CeeNU (lomustine) which include:
More about CeeNU (lomustine)
- CeeNU consumer information
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.